EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 7.76 Delayed Data As of Jul 01 |  -0.11 / -1.40%Today’s Change | 7.00 Today|||52-Week Range 21.50 | -36.60% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Lurker Nancy Sue President & Chief Executive Officer |  Sale | 11/15/2021 | 10,000 | $20.15 | $201.5K | -45.80% |
Paggiarino Dario A Chief Medical Officer | Sale | 2/09/2022 | 1,721 | $10.13 | $17.4K | -23.49% |
Jones Scott /eyepoint/ Chief Commercial Officer & Senior Vice President | Sale | 2/09/2022 | 1,473 | $10.13 | $14.9K | -23.49% |
Paggiarino Dario A Chief Medical Officer | Sale | 2/28/2022 | 1,294 | $9.95 | $12.9K | -22.11% |
Pine Michael C |  Buy | 3/14/2022 | 1,000 | $12.21 | $12.2K | -36.73% |
Jones Scott /eyepoint/ Chief Commercial Officer & Senior Vice President | Sale | 2/28/2022 | 1,130 | $9.95 | $11.2K | -22.11% |
Lurker Nancy Sue President & Chief Executive Officer | Buy | 2/09/2022 | 17,533 | $0.00 | $0.00 | -23.49% |
Jones Scott /eyepoint/ Chief Commercial Officer & Senior Vice President | Buy | 2/09/2022 | 4,966 | $0.00 | $0.00 | -23.49% |
Paggiarino Dario A Chief Medical Officer | Buy | 2/09/2022 | 4,966 | $0.00 | $0.00 | -23.49% |
Guyer David R Director | Buy | 2/09/2022 | 2,500 | $0.00 | $0.00 | -23.49% |
Page of 2